The Globe and Mail reports in its Friday, Oct. 16, edition that National Bank Financial analyst Maxim Sytchev calls Atkinsrealis Group one of his "top ideas." The Globe's David Leeder writes in the Eye On Equities column that Mr. Sytchev has reaffirmed his "outperform" recommendation and $108 share target. Analysts on average target the shares at $117.17. Mr. Sytchev says in a note: "Nuclear is transformational in terms of scale and is not contingent on the U.S. AI buildout. Top line for this division could hit $7-billion by 2031E vs. the current run rate of $2.5-billion if new builds in Ontario go its way. We don't believe the shares are anywhere close to reflecting this potential." The Globe reported on Dec. 16 and March 3 that Mr. Sytchev rated Atkinsrealis Group "outperform." The shares could then be had for $88.20 and $96.91. The Globe reported on Aug. 11 that Aug. 11, edition that RBC Capital Markets analyst Sabahat Khan has reaffirmed his "outperform" recommendation for Atkinsrealis when it could be had for $87.37. The Globe reported on Aug. 31 that Brompton Funds chief investment officer Laura Lau said she was unloading her Atkinsrealis because of "economic uncertainty." The share were then going for $84.87.